|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/04 | (2006.01) |
| A61K 31/203 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Patento numeris | 3191187 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15839752.1 |
| Europos patento paraiškos padavimo data | 2015-09-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/048899 |
| Data | 2015-09-08 |
| (87) | Numeris | WO 2016/040294 |
| Data | 2016-03-17 |
| (30) | Numeris | Data | Šalis |
| 201462047877 P | 2014-09-09 | US | |
| 201462087287 P | 2014-12-04 | US |
| (72) |
LOKHORST, Henk M. , NL
MUTIS, Tuna , NL
NIJHOF, Inger S. , NL
VAN DE DONK, Niels W. , NL
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES |
| COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES |